Scientist celebrates life-changing weight loss as generic Ozempic heads to Sask. - CBC

AI Briefing

• – Scientists in the US are celebrating a life-changing weight loss success using generic versions of the diabetes medication Ozempic, which is set to be approved for weight loss in Saskatchewan.
• – The generic version of the medication, which is currently sold in Canada for diabetes treatment, was approved for weight loss in the US in 2021.
• – The approval is expected to make the medication more affordable for Canadians seeking to lose weight and improve their health.